Literature DB >> 1997426

Cell and receptor requirements for streptococcal pyrogenic exotoxin T-cell mitogenicity.

B A Leonard1, P K Lee, M K Jenkins, P M Schlievert.   

Abstract

Streptococcal pyrogenic exotoxins (SPEs) A, B, and C, like other members of the pyrogenic toxin family, are able to cause toxic shock-like syndromes. One of the major properties of these toxins is the ability to induce T-cell proliferation. Characterization of T cell mitogenicity associated with SPEs A, B, and C was undertaken. SPEs A, B, and C were mitogenic for C57BL10/SnJ and BALB/cWAT T cells, with activities differing in intensity depending on the mouse strain and toxin employed. SPE-induced, T-cell-proliferative activity was dependent on class II major histocompatibility complex molecules expressed on antigen-presenting cells. The abilities of SPEs A, B, and C to preferentially stimulate murine cells with certain T-cell receptor V beta s were investigated by fluorescence-activated cell sorter analysis. SPE A preferentially activated T cells expressing V beta 8 but not V beta 3, 6, or 11, while SPEs B and C preferentially stimulated T cells which did not express any of the tested V beta s.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1997426      PMCID: PMC258393          DOI: 10.1128/iai.59.3.1210-1214.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes.

Authors:  L A Cone; D R Woodard; P M Schlievert; G S Tomory
Journal:  N Engl J Med       Date:  1987-07-16       Impact factor: 91.245

2.  The nucleotide and partial amino acid sequence of toxic shock syndrome toxin-1.

Authors:  D A Blomster-Hautamaa; B N Kreiswirth; J S Kornblum; R P Novick; P M Schlievert
Journal:  J Biol Chem       Date:  1986-11-25       Impact factor: 5.157

3.  Nonspecific T-lymphocyte mitogenesis by pyrogenic exotoxins from group A streptococci and Staphylococcus aureus.

Authors:  P M Schlievert; D J Schoettle; D W Watson
Journal:  Infect Immun       Date:  1979-09       Impact factor: 3.441

4.  Characterization of the human cellular immune response to purified group A streptococcal blastogen A1.

Authors:  W E Regelmann; E D Gray; L W Wannamaker
Journal:  J Immunol       Date:  1982-04       Impact factor: 5.422

5.  Expression of the cloned toxic shock syndrome toxin 1 gene (tst) in vivo with a rabbit uterine model.

Authors:  J C de Azavedo; T J Foster; P J Hartigan; J P Arbuthnott; M O'Reilly; B N Kreiswirth; R P Novick
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

6.  Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome.

Authors:  P M Schlievert; K N Shands; B B Dan; G P Schmid; R D Nishimura
Journal:  J Infect Dis       Date:  1981-04       Impact factor: 5.226

7.  Nonspecific and specific immunological mitogenicity by group A streptococcal pyrogenic exotoxins.

Authors:  E L Barsumian; P M Schlievert; D W Watson
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

8.  Toxicity of staphylococcal toxic shock syndrome toxin 1 in rabbits.

Authors:  J C de Azavedo; J P Arbuthnott
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

9.  Toxic-shock-syndrome toxin 1-induced proliferation of lymphocytes: comparison of the mitogenic response of human, murine, and rabbit lymphocytes.

Authors:  N J Poindexter; P M Schlievert
Journal:  J Infect Dis       Date:  1985-01       Impact factor: 5.226

10.  A rabbit model of toxic shock syndrome that uses a constant, subcutaneous infusion of toxic shock syndrome toxin 1.

Authors:  J Parsonnet; Z A Gillis; A G Richter; G B Pier
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

View more
  10 in total

Review 1.  Extracellular enzymes with immunomodulating activities: variations on a theme in Streptococcus pyogenes.

Authors:  Mattias Collin; Arne Olsén
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

2.  Relative abilities of distinct isotypes of human major histocompatibility complex class II molecules to bind streptococcal pyrogenic exotoxin types A and B.

Authors:  K Imanishi; H Igarashi; T Uchiyama
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

3.  Distinct T-cell receptor V beta gene usage by human T lymphocytes stimulated with the streptococcal pyrogenic exotoxins and pep M5 protein.

Authors:  M A Tomai; P M Schlievert; M Kotb
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

4.  Immune cell lethality induced by streptococcal pyrogenic exotoxin A and endotoxin.

Authors:  B A Leonard; P M Schlievert
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

5.  Structural basis for the recognition of superantigen streptococcal pyrogenic exotoxin A (SpeA1) by MHC class II molecules and T-cell receptors.

Authors:  A C Papageorgiou; C M Collins; D M Gutman; J B Kline; S M O'Brien; H S Tranter; K R Acharya
Journal:  EMBO J       Date:  1999-01-04       Impact factor: 11.598

6.  Separation of T-cell-stimulating activity from streptococcal M protein.

Authors:  B Fleischer; K H Schmidt; D Gerlach; W Köhler
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

7.  Exclusion of bioactive contaminations in Streptococcus pyogenes erythrogenic toxin A preparations by recombinant expression in Escherichia coli.

Authors:  U Fagin; U Hahn; J Grötzinger; B Fleischer; D Gerlach; F Buck; A Wollmer; H Kirchner; L Rink
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

8.  Analysis of the superantigenic activity of mutant and allelic forms of streptococcal pyrogenic exotoxin A.

Authors:  J B Kline; C M Collins
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

Review 9.  Superantigens and pseudosuperantigens of gram-positive cocci.

Authors:  B Fleischer; D Gerlach; A Fuhrmann; K H Schmidt
Journal:  Med Microbiol Immunol       Date:  1995-05       Impact factor: 3.402

10.  Role of human major histocompatibility complex DQ molecules in superantigenicity of streptococcus-derived protein.

Authors:  Y Esaki; Y Fukui; T Sudo; K Yamamoto; T Inamitsu; Y Nishimura; K Hirokawa; A Kimura; T Sasazuki
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.